These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 17936399
1. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice. Akahori T, Sho M, Hamada K, Suzaki Y, Kuzumoto Y, Nomi T, Nakamura S, Enomoto K, Kanehiro H, Nakajima Y. J Hepatol; 2007 Dec; 47(6):784-92. PubMed ID: 17936399 [Abstract] [Full Text] [Related]
2. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats. Cao Z, Ye P, Long C, Chen K, Li X, Wang H. Pharmacology; 2007 Dec; 79(3):184-92. PubMed ID: 17356310 [Abstract] [Full Text] [Related]
3. Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice. Kuzumoto Y, Sho M, Ikeda N, Hamada K, Mizuno T, Akashi S, Tsurui Y, Kashizuka H, Nomi T, Kubo A, Kanehiro H, Nakajima Y. Hepatology; 2005 Sep; 42(3):608-17. PubMed ID: 16108069 [Abstract] [Full Text] [Related]
4. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury. Doi S, Masaki T, Arakawa T, Takahashi S, Kawai T, Nakashima A, Naito T, Kohno N, Yorioka N. Transplantation; 2007 Jul 27; 84(2):207-13. PubMed ID: 17667812 [Abstract] [Full Text] [Related]
5. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. Ito K, Shimada J, Kato D, Toda S, Takagi T, Naito Y, Yoshikawa T, Kitamura N. Eur J Cardiothorac Surg; 2004 Apr 27; 25(4):530-6. PubMed ID: 15037267 [Abstract] [Full Text] [Related]
6. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders. Honda T, Kaikita K, Tsujita K, Hayasaki T, Matsukawa M, Fuchigami S, Sugiyama S, Sakashita N, Ogawa H, Takeya M. J Mol Cell Cardiol; 2008 May 27; 44(5):915-26. PubMed ID: 18436235 [Abstract] [Full Text] [Related]
7. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Abdelrahman M, Sivarajah A, Thiemermann C. Cardiovasc Res; 2005 Mar 01; 65(4):772-81. PubMed ID: 15721857 [Abstract] [Full Text] [Related]
8. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S, Graham SH, Chen J. J Neurochem; 2006 Apr 01; 97(2):435-48. PubMed ID: 16539667 [Abstract] [Full Text] [Related]
9. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Villegas I, Martín AR, Toma W, de la Lastra CA. Eur J Pharmacol; 2004 Nov 28; 505(1-3):195-203. PubMed ID: 15556153 [Abstract] [Full Text] [Related]
10. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment. Grommes C, Landreth GE, Sastre M, Beck M, Feinstein DL, Jacobs AH, Schlegel U, Heneka MT. Mol Pharmacol; 2006 Nov 28; 70(5):1524-33. PubMed ID: 16887936 [Abstract] [Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Kuboki S, Shin T, Huber N, Eismann T, Galloway E, Schuster R, Blanchard J, Zingarelli B, Lentsch AB. Hepatology; 2008 Jan 28; 47(1):215-24. PubMed ID: 18085707 [Abstract] [Full Text] [Related]
13. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. Lee KS, Kim SR, Park SJ, Park HS, Min KH, Jin SM, Lee MK, Kim UH, Lee YC. J Allergy Clin Immunol; 2006 Jul 28; 118(1):120-7. PubMed ID: 16815147 [Abstract] [Full Text] [Related]
14. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. Park SW, Yi JH, Miranpuri G, Satriotomo I, Bowen K, Resnick DK, Vemuganti R. J Pharmacol Exp Ther; 2007 Mar 28; 320(3):1002-12. PubMed ID: 17167171 [Abstract] [Full Text] [Related]
15. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats. Yamamoto Y, Ono T, Dhar DK, Yamanoi A, Tachibana M, Tanaka T, Nagasue N. J Gastroenterol Hepatol; 2008 Jun 28; 23(6):930-7. PubMed ID: 18565023 [Abstract] [Full Text] [Related]
16. PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition. Lee KJ, Jang YH, Lee H, Yoo HS, Lee SR. Eur J Neurosci; 2008 Jan 28; 27(2):334-42. PubMed ID: 18215232 [Abstract] [Full Text] [Related]
17. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Collino M, Aragno M, Mastrocola R, Gallicchio M, Rosa AC, Dianzani C, Danni O, Thiemermann C, Fantozzi R. Eur J Pharmacol; 2006 Jan 13; 530(1-2):70-80. PubMed ID: 16386242 [Abstract] [Full Text] [Related]
18. Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma. Kim SR, Lee KS, Park HS, Park SJ, Min KH, Jin SM, Lee YC. Mol Pharmacol; 2005 Dec 13; 68(6):1568-75. PubMed ID: 16150927 [Abstract] [Full Text] [Related]
19. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Sánchez-Hidalgo M, Martín AR, Villegas I, Alarcón De La Lastra C. Biochem Pharmacol; 2005 Jun 15; 69(12):1733-44. PubMed ID: 15876425 [Abstract] [Full Text] [Related]
20. Protective effect of endogenous PPARgamma against acute gastric mucosal lesions associated with ischemia-reperfusion. Wada K, Nakajima A, Takahashi H, Yoneda M, Fujisawa N, Ohsawa E, Kadowaki T, Kubota N, Terauchi Y, Matsuhashi N, Saubermann LJ, Nakajima N, Blumberg RS. Am J Physiol Gastrointest Liver Physiol; 2004 Aug 15; 287(2):G452-8. PubMed ID: 15246971 [Abstract] [Full Text] [Related] Page: [Next] [New Search]